Document:

Settlement Agreement

 Exhibit 10.12 
 SETTLEMENT AGREEMENT AND MUTUAL GENERAL RELEASE 
 This Settlement Agreement and Mutual General
Release (“Settlement Agreement”) is made as of September 5, 2007 (“Effective Date”) by and between Cogent, Inc. (“Cogent”), on the one hand, and Northrop Grumman Corporation, Northrop Grumman
Information Technology Overseas, Inc., Northrop Grumman Information Technology, Inc., Northrop Grumman Space & Mission Systems Corp., and Northrop Grumman Commercial Systems, Inc. (collectively referred to in the singular below as
“Northrop”), on the other hand, (collectively, “Parties”). 
 WHEREAS, on April 20, 2005, Cogent filed
an action in the California Superior Court in and for the County of Los Angeles, Case No. BC332199, styled Cogent Systems, Inc. v. Northrop Grumman, et al. (“Action”); 
 WHEREAS, as of the date of this Settlement Agreement, the operative complaint in the Action was the Fourth Amended Complaint, which asserts claims
against Northrop for declaratory and injunctive relief, specific performance, replevin, breach of contract, conversion and trade secret misappropriation, breach of trust and confidence, unfair competition, intentional interference with prospective
economic advantage, and intentional interference with contract; 
 WHEREAS, Northrop has denied, and continues to deny, the claims asserted
and allegations made against it in the Action, and has denied, and continues to deny, that it is liable to Cogent in any amount, or for any reason, whatsoever; and 
 WHEREAS, in order to avoid the cost, expense, and vagaries of litigation, the Parties wish to compromise, satisfy, settle, discharge, and release, in full all rights, claims, allegations, and causes of action alleged
in the Action, without further dispute or any other action of whatever type; 
  

 -1- 

 NOW, THEREFORE, in consideration of the mutual promises, releases and agreements herein, the
Parties hereto, for themselves and their respective subsidiaries, successors and assigns, agree as follows: 
 1. Payment. 

1.1 Northrop shall pay to Cogent the sum of U.S. $25,000,000 by wire transfer to an account designated by Cogent as follows:

 1.1.1 Fifteen Million Dollars ($15,000,000) on or after January 2, 2008, but no later than January 10, 2008; and

 1.1.2 Ten Million Dollars ($10,000,000) on or after January 2, 2009, but no later than January 12, 2009.

 1.2 Full and final execution and delivery of the Settlement Agreement and each of the Related Agreements by Cogent is a
condition precedent to Northrop’s payment obligations pursuant to subparagraphs 1.1.1 and 1.1.2 above. 
 2. Related Agreements.

 2.1 Simultaneous with the execution of this Settlement Agreement, the following Parties shall enter into the following
agreements (collectively, “Related Agreements”): 
 2.1.1 A Software License Agreement between Cogent and
Northrop Grumman Corporation and its wholly owned subsidiaries and in the form attached as Exhibit A; 
 2.1.2 A Products and
Services Agreement between Cogent and Northrop Grumman Corporation and its wholly owned subsidiaries and in the form attached as Exhibit B; and 
 2.1.3 A Strategic Alliance Agreement between Cogent and Northrop Grumman Corporation in the form attached as Exhibit C. 
  

 -2- 

 2.2 Full and final execution and delivery of each of the Related Agreements is a
condition precedent to the effectiveness of this Settlement Agreement. From and after the date of the Parties’ execution of this Settlement Agreement, the terms of the Related Agreements and this Settlement Agreement shall be confidential, and
shall not further be disclosed by the Parties to any other persons, entities or organizations, except: 
 2.2.1 to the extent
such terms were known by or have been available to the public as of the date of the Parties’ execution of this Settlement Agreement; 
 2.2.2 to the extent such terms become available to the public otherwise than by breach of this Settlement Agreement; 
 2.2.3 to actual or prospective customers of either of the Parties; 
 2.2.4 to the extent
required by an order of a court having jurisdiction or under subpoena from a court of law or an appropriate government agency (in which event, the Party receiving any such subpoena or order shall give written notice to the other Party three
(3) business days prior to responding); 
 2.2.5 in order for a Party to obtain legal, accounting or tax services;

 2.2.6 in order to enforce this Settlement Agreement; 
 2.2.7 as may be required by a Party to comply with applicable law, including the disclosure requirements of the federal securities laws
and the listing requirements of any exchange on which the securities of Cogent or Northrop may be listed; or 
 2.2.8 as
otherwise specified in the Related Agreements. 
  

 -3- 

 3. Release of Northrop. 
 3.1 Except as to such rights or claims as may be created by this Settlement Agreement or by any of the Related Agreements, Cogent hereby
releases, remises, and forever discharges: 
 3.1.1 Northrop and each of its successors, predecessors, affiliates, parents,
subsidiaries, employees, agents, representatives, officers, directors, attorneys, sureties, or insurers; 
 3.1.2 the National
Policing Improvement Agency (“NPIA”), the Police Information Technology Organisation (“PITO”), UK Home Office, UK Foreign & Commonwealth Office, UKvisas, and policing agencies and/or forces that are or have
been end users of the NAFIS and/or IDENT1 services and/or systems (collectively, “UK Customers”); and 
 3.1.3 Sagem Defense Securite (“SAGEM”) and ARGTEC, Inc. (“ARGTEC”), but only with respect to claims arising out of Northrop’s disclosure or transfer of any Cogent proprietary information to SAGEM or
ARGTEC or SAGEM or ARGTEC’s use of any such proprietary information or information derived therefrom. 
 3.2 Except as
set forth in Paragraph 4 below, the release of the entities named in subparagraph 3.1 above (collectively, the “Northrop Released Parties”) shall include any and all claims (including claims which were or could have been brought in
the Action), demands, debts, losses, obligations, warranties, costs, expenses, rights of action and causes of action, of every kind and nature whatsoever, whether based on contract, tort, statutory or other legal or equitable theory of recovery,
known or unknown, suspected or unsuspected, existing, or claimed to exist, which Cogent ever held or had, now holds or has, or may claim to hold or have, as of the Effective Date, or which are based either in whole or in part on any materials that
may be returned by Northrop to Cogent or destroyed by Northrop pursuant to Paragraph 11 of this Settlement Agreement (the “Northrop Released Claims”). 
  

 -4- 

 4. Representations and Warranties by Northrop. Northrop represents and warrants that it is not
using any Cogent Source Code or Cogent Object Code (as such terms are defined in Paragraphs 11.1 and 11.2 below) on any program, including the IDENT1, ABIS and CIS projects as described in the Software License Agreement. The Northrop Released Claims
shall not include any claims arising out of any breach of the representations and warranties in this Paragraph 4; provided, however, that any such breach shall not in any way negate or affect either the release of any of the Northrop Released
Claims or the enforceability of this Settlement Agreement. 
 5. Release of Cogent. Except as to such rights or claims as may be
created by this Settlement Agreement or the Related Agreements, Northrop hereby releases, remises, and forever discharges Cogent and each of its successors, predecessors, affiliates, parents, subsidiaries, employees, agents, representatives,
officers, directors, attorneys, sureties, or insurers (the “Cogent Released Parties”) from any and all claims (including claims which could have been brought as counter-claims in the Action), demands, debts, losses, obligations,
warranties, costs, expenses, rights of action and causes of action, of every kind and nature whatsoever, whether based on contract, tort, statutory or other legal or equitable theory of recovery, known or unknown, suspected or unsuspected, existing,
or claimed to exist, which Northrop ever held or had, now holds or has, or may claim to hold or have, as of the Effective Date (the “Cogent Released Claims”). 
  

 -5- 

 6. Representations and Warranties by Cogent. Cogent represents and warrants that it is not using
any Northrop Source Code or Northrop Object Code (as such terms are defined below) on any program. The Northrop Released Claims shall not include any claims arising out of any breach of the representations and warranties in this Paragraph 6;
provided, however, that any such breach shall not in any way negate or affect either the release of any of the Cogent Released Claims or the enforceability of this Settlement Agreement. “Northrop Source Code” shall mean all
algorithms and/or source code (including algorithms contained in any such source code), that was provided by TRW and/or Northrop to Cogent at any time, in whatever form or medium of storage (including any compilations of such code), including,
without limitation, all fingerprint minutia filtering routines, as well as any alterations, revisions, modifications and/or annotations of such source code and all copies thereof. “Northrop Object Code” shall mean any object and/or
executable code within Cogent’s possession that was provided by TRW and/or Northrop to Cogent at any time or which was created by Cogent by compiling Northrop Source Code, in whatever form or medium of storage (including any load images of such
code), including, without limitation, all fingerprint minutia filtering routines, as well as any alterations, revisions, modifications and/or annotations of such source code and all copies thereof. 
 7. California Civil Code Section 1542 Waiver. In furtherance of the Parties’ intention that the Settlement Agreement be in full and
final accord and satisfaction of the claims or potential claims which are the subject of the Settlement Agreement, and except as provided in Paragraphs 4 and 6 above, each Party hereto expressly waives the benefit of the provisions of
Section 1542 of the Civil Code of the State of California, which provides as follows: 
 A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS
WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR. 
  

 -6- 

 8. Attorneys’ Fees. Each of the Parties hereto will bear its own costs and attorneys’
fees incurred in connection with the Action and this Settlement Agreement. 
 9. Dismissal. Upon execution and delivery of this
Settlement Agreement and each of the Related Agreements, counsel for Cogent and Northrop shall promptly execute and file a Stipulation of Dismissal with Prejudice of the Action substantially in the form of Exhibit D annexed hereto (the
“Dismissal”). The Parties each represent that, to the best of their knowledge, there are no other pending actions arising out of or relating in any way to the Action or to the claims and/or facts which were alleged or could have
been brought in the Action. 
 10. Return or Disposal of Discovery Material. With respect to the disposition of materials produced by
the Parties during the course of discovery in the Action, the Parties each agree as follows: 
 10.1 Within ninety
(90) days after the filing of the Dismissal, each of the Parties shall return to the Producing Party or destroy (and certify to the Producing Party the return and/or destruction of) all Discovery Material and all copies of such materials,
including, without limitation, all Confidential Discovery Material and Highly Confidential Discovery Materials received from the Producing Party. “Producing Party,” “Discovery Material,” “Confidential
Discovery Material,” and “Highly Confidential Discovery Material” shall have the meanings set forth in the Protective Order entered in the Action on February 7, 2006 (the “Protective Order”). Discovery
Materials required to be returned or destroyed pursuant to this Paragraph 10 shall be referred to herein as the “Disposed Materials.” 
 10.2 The Parties’ obligations to return or destroy Discovery Materials shall include all materials and copies provided to any expert, consultant, or other third party. 
  

 -7- 

 10.3 Notwithstanding any provisions of this Settlement Agreement, the Parties agree that
their respective outside counsel shall have the right to archive and retain for a period of ten (10) years one (1) hard copy and one (1) electronic copy of the following files regardless of whether they contain Discovery Materials
received from outside counsel for the opposing party: correspondence files (excluding any document productions, whether in hard copy or in electronic form, included as enclosures or attachments to correspondence from outside counsel for the opposing
Party); pleading files; written discovery requests and written responses served in the Action (excluding any document productions, whether in hard copy or in electronic form by an opposing Party); and transcripts of depositions taken in the action,
including exhibits (collectively, the “Retained Discovery Materials”); provided, however, that, except as provided in Paragraph 11.6 below and except as to deposition transcripts and exhibits to transcripts of depositions,
Cogent outside counsel may not retain any Discovery Materials or other writings, in whatever form, medium or embodiment, that contain any Northrop Source Code produced by Northrop in the Action, and Northrop outside counsel may not retain any
Discovery Materials or other writings, in whatever form, medium or embodiment, that contain any Cogent Source Code produced by Cogent in the Action. 
 10.4 Each Party further agrees to instruct its outside counsel to archive and retain, notwithstanding any other provisions of this Settlement Agreement, for a period of ten (10) years one (1) copy of all
Discovery Material, including, without limitation, all Confidential Discovery Material and Highly Confidential Discovery Materials, produced by that Party in the Action. The Parties agree that counsel may retain one (1) hard copy and one
(1) electronic copy of such materials notwithstanding any other provisions of this Settlement Agreement. 
  

 -8- 

 10.5 With respect to (i) all Disposed Materials (pending their return and/or
destruction pursuant to this Paragraph 10), and (ii) all Retained Discovery Materials, the Parties shall not use such materials for any purpose or disclose or provide such materials to any person, except to the extent required by an order of a
court having jurisdiction or under subpoena from a court of law or an appropriate government agency (in which event, the Party receiving any such subpoena or order shall give written notice to the other Party three (3) business days prior to
responding). 
 11. Return, Disposal and/or Retrieval of Cogent Trade Secret and Other Information. In addition to its obligation to
destroy Discovery Materials set forth in Paragraph 10, above, Northrop agrees, represents and warrants that it shall, within ninety (90) days after the filing of the Dismissal, do the following: 
 11.1 As to all algorithms and/or source code (including algorithms contained in such source code) within Northrop’s possession that
was provided by Cogent to TRW and/or to Northrop prior to the Effective Date, in whatever form or medium of storage (including any compilations of such code), including, without limitation, all fingerprint encoding routines (including version 5.03
and earlier), fingerprint matching routines (including version 6.04 and earlier), and all fingerprint minutia filtering routines (including version 1.5 and all earlier), as well as any revisions, modifications and/or annotations of such source code
(collectively “Cogent Source Code”) and all copies thereof: 
 11.1.1 Use reasonable efforts to locate and
collect all Cogent Source Code; 
  

 -9- 

 11.1.2 Where Cogent Source Code exists on tapes and in a form discrete from Northrop or
third-party source code or information, at Cogent’s option, return or destroy (and certify the return and/or destruction of) the Cogent Source Code; and 
 11.1.3 Where Cogent Source Code exists in a form other than tapes and/or in a form that is not discrete from Northrop or third-party
source code or information, destroy (and certify the destruction of) the Cogent Source Code. 
 11.2 As to all Cogent object
and/or executable code within Northrop’s possession that was provided by Cogent to TRW and/or to Northrop prior to the Effective Date or which was created by Northrop by compiling Cogent Source Code, in whatever form or medium of storage
(including any load images of such code), including, without limitation, all fingerprint encoding routines (including version 5.03 and earlier), fingerprint matching routines (including version 6.04 and earlier), and all fingerprint minutia
filtering routines (including version 1.5 and earlier), as well as any alteration, modification and/or annotation of such object code (collectively “Cogent Object Code”) and all copies thereof: 
 11.2.1 Use reasonable efforts to locate and collect all Cogent Object Code within its possession; and 
 11.2.2 Return or destroy (and certify the return and/or destruction of) all Cogent Object Code, whether or not in a form discrete from
Northrop or third-party code. 
 11.3 As to all data structure and data format information within Northrop’s possession
that identifies or describes all or any part of any format in which any Cogent software extracts, encodes, stores and/or processes information, provided by Cogent to TRW and/or to Northrop as of the Effective Date, in whatever form or medium of
storage, including, without limitation, the .hwf format (“ Data Format Information”): 
 11.3.1 Use
reasonable efforts to locate and collect all Data Format Information; and 
  

 -10- 

 11.3.2 Return or destroy (and certify the return and/or destruction of) all Data Format
Information, whether or not in a form discrete from Northrop or third-party information. 
 11.3.3 For purposes of this
Settlement Agreement, Data Format Information does not include data encoded in the .mnt format, the .hwf format, or in any other format in which Cogent software extracts, encodes stores and/or processes information, as opposed to information which
defines the format itself. 
 11.4 As to any of the documents identified in Exhibit E to this Settlement Agreement
(“Additional Information”) and in Northrop’s possession, use reasonable efforts to locate and collect and to return or destroy (and certify the return and/or destruction of) the documents. 
 11.5 Northrop may use vendors to locate, collect, return and/or destroy the Cogent Source Code, Cogent Object Code, Data Format
Information, and Cogent Information as set forth above; provided that Northrop shall: 
 11.5.1 obtain the prior written
agreement of any vendor engaged in such activities to keep all information contained in such materials confidential; and 
 11.5.2 remain responsible for ensuring that reasonable efforts are undertaken to locate and collect all such documents. 
 11.6 Notwithstanding any other provision of this Settlement Agreement, outside counsel for Northrop may retain for a period of ten (10) years one (1) archive copy of each NAFIS and IDENT1 source code release prior to source code
release 20.5, which prior releases may contain Cogent Source Code, Cogent Object Code, Data Format Information, and/or Cogent 

  

 -11- 

 
proprietary or confidential information. After ten (10) business days written notice to Cogent, Northrop may request counsel for access to the archive
copies and may review and analyze their contents as required to fulfill customer requirements on the IDENT1 program in effect as of the Effective Date. Northrop’s written notice to Cogent, to the extent possible given customer confidentiality
requirements, shall generally explain the reason for Northrop’s belief that its review and analysis of such materials is required for such purposes. In retaining the archive copies and/or providing access to the copies to Northrop, counsel for
Northrop shall owe no duties and shall incur no obligations to Cogent of any nature whatsoever. Cogent agrees not to assert any claim of any kind against counsel for Northrop arising out of or related to its retention of the archive copies and/or
providing access to the copies to Northrop; provided, however, that Cogent shall be entitled to seek injunctive relief to prevent disclosure of Cogent Source Code, Cogent Object Code, and/or Data Format Information to Northrop in the event
Northrop fails to generally establish that its review and analysis of such materials is necessary to fulfill customer requirements on the IDENT1 program in effect as of the Effective Date. 
 11.7 As to any third party, including, but not limited to, SAGEM or ARGTEC (but specifically excluding UK Customers, former Northrop and
TRW employees, individuals who have worked as consultants to Northrop, and vendors engaged in effort of the type provided in Paragraph 11.5 above) to whom Northrop believes it or TRW may have provided Cogent Source Code, Cogent Object Code, Data
Format Information and/or any rank order candidate results from any benchmark test of Cogent software (“Cogent Test Data”) before the Effective Date, Northrop agrees that it shall: 
 11.7.1 Within thirty (30) days from filing of the Dismissal, make a written demand to any such third party that it return and/or
destroy (and certify to Northrop the return and/or destruction of) any such materials, including all copies of any such materials, within thirty (30) days; 
  

 -12- 

 11.7.2 Provide Cogent a copy of each written demand and all written responses to each
such demand; and 
 11.7.3 Return to Cogent or destroy (and certify the return and/or destruction of) all materials returned
by said third party. 
 11.8 As to R.J. Langley and Robert Gerbracht, Northrop agrees that it shall: 
 11.8.1 Within thirty (30) days from filing of the Dismissal, send letters reminding them of any confidentiality obligations regarding
Cogent’s Source Code, Cogent Object Code, Data Format Information, and Cogent Test Data they may have under confidentiality agreements executed between them and TRW and/or Northrop, to the extent known by Northrop, and making a demand that they
return and/or destroy (and certify to Northrop the return and/or destruction of) any Cogent Source Code, Cogent Object Code, Data Format Information and/or any Cogent Test Data, including all copies of any such materials, within thirty
(30) days. 
 11.8.2 Return to Cogent or destroy (and certify the return and/or destruction of) all materials returned by
said third party. 
 11.9 Cogent acknowledges and agrees that, given, among other things, the size of an organization such as
Northrop, and despite Northrop’s exercise of reasonable efforts, Northrop may fail to (a) identify and/or locate all materials within the scope of subparagraphs 11.1 through 11.4 above within the ninety (90) day period from the filing
of the Dismissal, or at all; or 

  

 -13- 

 
(b) identify, and hence to send demands to, third parties within the scope of subparagraph 11.7 above within the (30) day period from the filing of
the Dismissal, or at all. Northrop’s failure to identify and/or locate all materials within the scope of subparagraphs 11.1 through 11.4 within the ninety (90) day period from the filing of the Dismissal or at all, despite exercise of
reasonable efforts, shall not constitute a breach of this Settlement Agreement. Northrop’s failure to identify, and hence to send demands to, all third parties as specified in Paragraph 11.7 above, within the thirty (30) day period from
the filing of the Dismissal, or at all, despite the exercise of reasonable efforts, shall not constitute a breach of this Settlement Agreement. 
 11.10 Should Northrop discover and/or receive additional materials subject to subparagraphs 11.1 through 11.4 after the ninety (90) day period from the filing of the Dismissal, Northrop shall promptly return,
destroy and/or retrieve such materials, as applicable. Should Northrop, after the time period specified in Paragraph 11.7, identify additional third parties to whom demands for return and/or destruction of materials should have been sent pursuant to
that paragraph, Northrop will promptly send out such demands and comply with all other provisions of Paragraph 11.7 with respect to those third parties. 
 11.11 Except as to any claims arising out of any breach of the representations and warranties in Paragraph 4 above, Cogent shall not assert against any of the Northrop Released Parties any claim, demand, obligation,
right of action or cause of action, of any kind and nature whatsoever, whether based on contract, tort, statutory or other legal or equitable theory of recovery, based on any materials or the content of any materials returned to it by Northrop or
destroyed by Northrop pursuant to the requirements of subparagraphs 11.1 through 11.4 and 11.7 above. 
  

 -14- 

 12. Rights in Technology and Information. With respect to the following technology and
information, the Parties agree as follows: 
 12.1 As of the filing of the Dismissal, Northrop acknowledges and agrees that
all Cogent Source Code is Cogent trade secret information and that Northrop has no right to use or to disclose to any third party any Cogent Source Code on or after the Effective Date. 
 12.2 As of the filing of the Dismissal, Northrop acknowledges and agrees that all Cogent Object Code is Cogent trade secret information
and that Northrop has no right to use or to disclose to any third party any Cogent Object Code on or after the Effective Date. 
 12.3 As of the filing of the Dismissal, Northrop acknowledges and agrees that Northrop has no right to use or to disclose to any third party any Cogent Data Format Information on or after the Effective Date, except as expressly may be
permitted by any of the Related Agreements and/or any future written agreements between Cogent and Northrop and/or its related entities. Notwithstanding the provisions of this Paragraph 12.3, Cogent agrees that, upon written request from Northrop
and at a price to be determined in accordance with the terms of the Products and Services Agreement referenced in Paragraph 2 above, Cogent shall convert, either to a NIST-9 format or to another public format designated by Northrop, any fingerprint
data formatted in the .hwf format and in the possession of, and/or used by or on, the NAFIS program and/or services or the IDENT1 program and/or services, or by the UK Customers. Cogent shall take reasonable steps to complete any such conversion
request within thirty (30) days of Northrop’s written request, subject to Cogent’s existing work requirements and resources, unless otherwise agreed to by the Parties in writing. After any such conversion, Northrop may utilize the
reformatted data for any purpose whatsoever Northrop’s request for and use of such converted data shall not constitute or be deemed to constitute a breach of this 

  

 -15- 

 
Settlement Agreement. Northrop shall have the right to encode images that may have been previously encoded in any other format using or embodying Cogent Data
Format Information, including without limitation the .hwf format, and Northrop shall not be liable to Cogent for the removal of Cogent Data Format Information from any previously existing data bases or storage materials. 
 12.4 The UK Customers shall have the right to convert data in existence in the .hwf format as of the time of execution of this Settlement
Agreement to other formats, and thereafter utilize the reformatted data for any purpose whatsoever. 
 12.5 Cogent recognizes
and hereby acknowledges and agrees, that the Release 20.5 version of IDENT1 program source code provided by Northrop’s counsel to Cogent’s counsel on August 17, 2007 does not contain, and is free of, Cogent Source Code, Cogent Object
Code, Data Format Information, and any form of Cogent proprietary information, trade secret information, technology and/or know how. 
 12.6 Northrop acknowledges and agrees that Cogent owns and has all interest in the Pattern Matching Accelerator (“PMA”) Boards. As used herein, “PMA Boards” means the multiple-layer, Field Programmable Gate
Array (“FPGA”) based printed circuit boards produced by Cogent and designed for high-speed fingerprint matching as of June 22, 2000. 
 12.7 Cogent acknowledges and agrees that Northrop owns and has all interest in the Fingerprint Match Accelerator (“FMA”) Boards. As used herein, “FMA Boards” means the multi-layer,
FPGA-based printed circuit boards developed and produced by TRW or which TRW paid to have developed and/or produced and designed to act as a coarse fingerprint matcher as of June 22, 2000. 
  

 -16- 

 12.8 Northrop shall not disclose any Cogent Test Data to any third party, other than the
UK Customers, and then only as requested by such parties and/or as required under the NAFIS or IDENT1 contracts. 
 13.
Confidentiality. Northrop acknowledges and agrees that it shall not disclose to any third party any information, whether or not in written or other tangible form, describing or identifying the content of Cogent Source Code, Cogent Object
Code, Data Format Information, or Cogent Test Data, except as expressly set forth herein or in the Related Agreements. 
 14. Cooperation.
The Parties agree to cooperate fully and execute any and all additional documents and take any and all additional action as may be necessary and appropriate to give full force and effect to the terms and intent of this Settlement Agreement, and
each of the Related Agreements. 
 15. Disputes and Choice of Law. The Parties stipulate and agree that this Settlement Agreement is
enforceable pursuant to California Code of Civil Procedure § 664.6 and that the Los Angeles County Superior Court may retain jurisdiction to enforce it; provided, however, that any dispute between the Parties relating to any alleged
breach of this Settlement Agreement shall be resolved pursuant to the dispute resolution procedures set forth below, that resolution of all disputes regarding the Related Agreements shall be subject to the dispute resolution procedures specified in
those agreements, and that any breach of this Settlement Agreement shall not provide any ground for rescission of the Settlement Agreement by either Party. 
 15.1 This Settlement Agreement shall be governed by, and interpreted, construed and enforced in accordance with, the laws of the State of California, without reference to its conflicts of laws principles without
giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties. 
  

 -17- 

 15.2 The Parties agree to attempt to settle any claim or controversy arising out of this
Settlement Agreement through consultation and negotiation in good faith and a spirit of mutual cooperation. Any dispute between the Parties relating to this Settlement Agreement will first be submitted in writing to a panel comprised of a senior
executive, with a rank of Vice President or above, from Northrop and Cogent, who will promptly confer in an effort to resolve such dispute. The executives will be identified by written notice and may be changed any time thereafter by written notice.
Any agreed decisions of the executives will be final and binding on the Parties. 
 15.3 In the event the executives are
unable to resolve any dispute within thirty (30) days after submission to them, the Parties agree to resolve the dispute by binding arbitration. Arbitration shall be held in Los Angeles, California in accordance with the JAMS Comprehensive
Arbitration Rules and Procedures (“JAMS Rules”); provided, that the California Code of Civil Procedure, Rules of Evidence and discovery rules of California shall apply to the arbitration of disputes hereunder. Arbitration
shall be conducted by one arbitrator (who shall be a retired or former judge), independent of any of the Parties, mutually selected from a list provided by JAMS in accordance with such JAMS Rules. In the event that Northrop and Cogent cannot agree
to an arbitrator, they shall each select an arbitrator and such arbitrators shall select a third arbitrator that will act as the arbitrator for disputes hereunder. In circumstances requiring expedited relief, the selection of the arbitrator shall be
completed within three (3) business days of the commencement of the arbitration. The arbitrator shall make his or her decision in writing at the earliest convenient date. The arbitrator shall be bound to apply the applicable substantive law set
forth herein to each dispute. 

  

 -18- 

 
The arbitrator shall decide in accordance with the express terms of the Settlement Agreement and shall take into account usages of the trade applicable to
this Settlement Agreement. The arbitrator is not empowered to alter, amend, modify or change any of the terms of this Settlement Agreement. The arbitrator shall be empowered to grant any remedy or relief that is just and equitable, including
specific performance and injunctive relief; provided, however, that the arbitrator shall not be empowered to award punitive or exemplary damages under any circumstances, whether statutory or common law in nature, and including but not limited
to, treble damages awarded by statute. If a Party against whom the arbitrator renders an award fails to abide by such award, the other Party may bring an action to enforce the same in any court of competent jurisdiction. Without limiting the
foregoing, the Parties may enforce any arbitration determination in any state or federal court in Los Angeles, California, over the Party against whom such arbitration determination is sought to be enforced. For the purpose of any action or
proceeding instituted with respect to any such arbitration determination, the Parties hereby irrevocably submit to the jurisdiction of such courts, irrevocably consent to the service of process by registered mail or personal service and hereby
irrevocably waive, to the fullest extent permitted by law, any objection which they may have or hereafter have as to personal jurisdiction, of any state or federal court in Los Angeles, California. The fees and expenses of the arbitrator shall be
divided equally between the Parties and paid by them accordingly. 
 15.4 In the event any action is brought to remedy,
prevent, or obtain relief from a breach of this Settlement Agreement, the arbitrator shall have the discretion to decide whether or not to award the prevailing Party reasonable attorney’s fees and expert fees and other reasonably incurred costs
and expenses in addition to any other relief to which that Party may be entitled; and shall also have discretion as to the amount of any such fees, costs, and expenses to be awarded; provided, however, that in the 

  

 -19- 

 
event any action is brought to remedy, prevent or obtain relief from a breach of the payment obligations set forth in Paragraph 1.1 of this Settlement
Agreement, the prevailing Party shall recover all reasonable attorney’s fees and expert fees and other reasonably incurred costs and expenses in addition to any other relief to which that Party may be entitled. 
 16. No Admission of Liability. The Parties hereto acknowledge that this Settlement Agreement is a compromise resolution of disputed claims for the
purpose of mitigating the costs, uncertainties, and burdens of further litigation and that nothing contained in this Settlement Agreement, including, but not limited to, the acknowledgements in Paragraph 12, or in or the Related Agreements
constitutes or should be construed as an acknowledgement or admission of liability in any way on the part of the Parties hereto, each of whom expressly denies any liability or wrongdoing in connection with any of the claims and/or counterclaims
asserted in the Action, and the Parties agree not to issue any public statements or comments to the contrary. 
 17. Binding Agreement.
This Settlement Agreement, and all of its terms and provisions, shall be binding on and inure to the benefit of the Parties and each of their present and future successors, predecessors, parents, subsidiaries, principals, assigns, employees,
agents, representatives, officers, directors, attorneys, sureties, and insurers. 
 18. Power and Authority. Each Party and each
signatory to this Settlement Agreement hereby represents and warrants that it has full power, authority and legal right to execute, deliver and perform all actions required under this Settlement Agreement and the Related Agreements. 
  

 -20- 

 19. No Other Actions. No other or further action is necessary for the Parties to enter into this
Settlement Agreement and all other documents contemplated hereby and thereby; however, should any further action or documents be necessary to implement this Settlement Agreement, the Parties agree to complete such action or documents promptly.

 20. No Assignment. The Parties each represent and warrant that there has been no assignment or attempted assignment of any rights
and/or claims that are the subject matter of this Settlement Agreement or the Related Agreements at any time prior to the signing of this Settlement Agreement. 
 21. Entire Agreement. This Settlement Agreement and the Related Agreements constitute the entire agreement among the Parties with respect to the subject matter hereof and supersede any prior and/or
contemporaneous oral or written agreements, negotiations and discussions with respect to the subject matter hereof. All agreements between the Parties and/or their predecessors or subsidiaries entered into prior to the Parties’ execution of
this Settlement Agreement are terminated, and each of the Parties’ obligations and rights thereunder are extinguished. The agreements terminated by this Settlement Agreement include without limitation: the June 22, 2000 Settlement
Agreement and Mutual General Release; the Confidentiality Agreement No. 78736 as executed as of November 9, 1994 (also known by the Parties as the “1994 Confidentiality Agreement”); the Confidentiality Agreement No. 78736 as
executed as of October 3, 2001 (also known by the Parties as the “2001 Confidentiality Agreement”); the August 1994 Agreement in Principle (also known by the Parties as the “Strategic Agreement”); and the February 1995
Agreement regarding the NAFIS Contract (also known by the Parties as the “UK NAFIS Agreement”). The Parties further acknowledge that, except as stated elsewhere in this Settlement Agreement, no Party (nor any officer, agent, employee,
representative, or attorney of or for any Party) has made any statement or representation to any other Party regarding any fact relied upon in entering into this Settlement Agreement, and each Party does not rely upon any statement, representation
or promise of any Party (or of any officer, 

  

 -21- 

 
agent, employee, representative, or attorney for the other Party) in executing this Settlement Agreement, or in making the settlement provided for herein,
except as expressly stated in this Settlement Agreement; and that no consideration has been offered, promised, expected or held out other than as may be expressly provided herein. 
 22. Modification. This Settlement Agreement may not be altered, modified or amended, unless by agreement in writing executed by the Parties or
their authorized representatives, nor any of its provisions waived, unless in writing by the Party granting such waiver. 
 23.
Waiver. Any failure of any Party to enforce any provision of this Settlement Agreement shall not (i) constitute or be construed as a waiver of such provision or otherwise prejudice the right of that Party to enforce such provision at any
subsequent time; or (ii) preclude such Party from enforcing any other rights or remedies that such Party may have under this Settlement Agreement. 
 24. Representation by Counsel. Each Party represents and warrants that it has been represented by legal counsel with respect to the negotiation of the terms of this Settlement Agreement, that it has been
advised by legal counsel as to its rights and obligations under this Settlement Agreement, and that it and its counsel have participated in the review and drafting of this Settlement Agreement. 
 25. Investigation. Each Party to this Settlement Agreement has made such investigation of the facts pertaining to this settlement and this
Settlement Agreement and of all the matters pertaining thereto as it deems necessary. Each Party has read this Settlement Agreement and understands its contents. 
  

 -22- 

 26. Interpretation. All Parties have had the opportunity to draft, review and edit the language of
this Settlement Agreement. Accordingly, no presumption for or against any Party arising out of drafting all or any part of this Settlement Agreement will be applied in any action relating to, connected to, or involving this Settlement Agreement; and
the Parties hereby waive the benefit of any statute, providing that in cases of uncertainty, language of a contract should be interpreted most strongly against the Party who caused the uncertainty to exist. 
 27. Headings. The headings of the sections of this Settlement Agreement are included for convenience only and shall not be deemed to constitute
part of this Settlement Agreement or to affect its construction. 
 28. Severability. In the event that any provisions of this
Settlement Agreement shall be held to be void, voidable, or unenforceable, the remaining portions of it shall remain in full force and effect. Should any Related Agreement, or any portion thereof, be held to be void, voidable or unenforceable, this
Settlement Agreement shall remain in full force and effect, and a Party’s breach of any obligation under any Related Agreement shall not constitute a breach of this Settlement Agreement, and this Settlement Agreement shall remain in full force
and effect despite any such breach. A Party’s breach of any obligation under this Settlement Agreement shall not constitute a breach of any of the Related Agreements, and those Related Agreements shall remain in full force and effect despite
any such breach. 
  

 -23- 

 29. Notices. Any and all notices, demands, or other communications required under this Settlement
Agreement (“Notices”) shall be in writing and delivered by receipted courier to the intended recipient at the addresses set forth below, or at such other address as any Party may designate by notice to the other. All notices shall
be deemed given when delivered to the address designated below, addressed to the attention of the person or persons designated below: 
  

			
	 Notices to Cogent
	  	 Notices to Northrop

		
	 Kirk D. Dillman, Esq.
 Hennigan, Bennett &
Dorman LLP
 865 South Figueroa Street, Suite 2900
 Los Angeles,
California 90017
 Telephone: (213) 694-1200
 Facsimile:
(213) 694-1234
  
 Carl E. Kohlweck, Esq.
 Cogent Systems
 209 Fair Oaks Avenue
 South Pasadena, California 91030
 Telephone: (626) 799-8090
 Facsimile: (626) 799-8996
	  	 Joseph F. Coyne, Jr., Esq.
 Sheppard, Mullin, Richter
& Hampton LLP
 333 South Hope Street, 48th Floor

 Los Angeles, California
 Telephone: (213) 620-1780

Facsimile: (213) 620-1398
  
 W. Burks Terry, Esq.
 Corporate Vice President and General Counsel
 Northrop Grumman Corp.
 1840 Century Park East, 18th Floor
 Los Angeles, California 90067

 The above-designated names and addresses may be changed by written notice delivered in the manner prescribed in
this paragraph. 
 30. Counterparts. This Settlement Agreement may be executed in one or more counterparts, each of which shall
constitute an original document. Delivery of an executed counterpart of this Settlement Agreement by facsimile transmission shall be as effective as delivery of a manually executed counterpart of this Settlement Agreement. 
 IN WITNESS WHEREOF, the Parties do execute this Settlement Agreement. 
  

									
	Dated: December 4, 2007	 		 	COGENT, INC.
					
		 		 		 	By:	 	/s/ Ming Hsieh
		 		 		 	Its:	 	CEO

  

 -24- 

									
	Dated: December 5, 2007	 		 	 NORTHROP GRUMMAN
 CORPORATION

					
		 		 		 	By:	 	/s/ Kathleen M. Salmas
		 		 		 	Its:	 	Assistant Secretary
			
	Dated: December 5, 2007	 		 	 NORTHROP GRUMMAN
 INFORMATION TECHNOLOGY
OVERSEAS, INC.

					
		 		 		 	By:	 	/s/ Kathleen M. Salmas
		 		 		 	Its:	 	Secretary
			
	Dated: December 5, 2007	 		 	 NORTHROP GRUMMAN
 INFORMATION TECHNOLOGY,
INC.

					
		 		 		 	By:	 	/s/ Kathleen M. Salmas
		 		 		 	Its:	 	Secretary
			
	Dated: December 5, 2007	 		 	 NORTHROP GRUMMAN
 SPACE & MISSION
SYSTEMS, CORP.

					
		 		 		 	By:	 	/s/ Kathleen M. Salmas
		 		 		 	Its:	 	Secretary
			
	Dated: December 5, 2007	 		 	 NORTHROP GRUMMAN
 COMMERCIAL SYSTEMS, INC.

					
		 		 		 	By:	 	/s/ Kathleen M. Salmas
		 		 		 	Its:	 	Secretary

  

 -25-Note Exchange Agreement

 Exhibit 10.1 
  

 NOTE EXCHANGE AGREEMENT 
 BY AND AMONG 
 CRITICAL PATH, INC. 
 AND 
 THE PERSONS NAMED ON SCHEDULE I HERETO 
 DATED AS OF December 5, 2007 
  

  

 TABLE OF CONTENTS 
  

					
	 	 	 	  	Page
	 ARTICLE I  EXCHANGE OF NOTES FOR COMMON STOCK
	  	2
			
	 Section 1.1
	 	Exchange of the Notes; Cancellation of the Series F Warrants	  	2
	 Section 1.2
	 	Closing	  	2
	 Section 1.3
	 	No Transfer	  	2
		
	 ARTICLE II  REPRESENTATIONS AND WARRANTIES OF THE COMPANY
	  	2
			
	 Section 2.1
	 	Corporate Existence and Power	  	3
	 Section 2.2
	 	Authorization, No Conflicts	  	3
	 Section 2.3
	 	Binding Effect	  	3
	 Section 2.4
	 	Approvals and Consents	  	3
	 Section 2.5
	 	Issuance of Exchanged Shares	  	3
		
	 ARTICLE III  REPRESENTATIONS AND WARRANTIES OF THE EXCHANGING NOTEHOLDERS
	  	4
			
	 Section 3.1
	 	Existence and Power	  	4
	 Section 3.2
	 	Authorization, No Conflicts	  	4
	 Section 3.3
	 	Binding Effect	  	4
	 Section 3.4
	 	Approvals and Consents	  	4
	 Section 3.5
	 	Status of Exchanging Noteholder	  	4
	 Section 3.6
	 	Purchase for Own Account	  	5
	 Section 3.7
	 	Title to Notes	  	5
	 Section 3.8
	 	Pre-existing Relationship	  	5
	 Section 3.9
	 	No Advertising	  	5
		
	 ARTICLE IV  CONDITIONS TO THE OBLIGATION OF THE PARTIES TO CLOSE
	  	5
			
	 Section 4.1
	 	Conditions to the Obligations of the Exchanging Noteholders to Close	  	5
	 Section 4.2
	 	Conditions to the Obligations of the Company to Close	  	6
		
	 ARTICLE V  TERMINATION
	  	6
			
	 Section 5.1
	 	Termination	  	6
	 Section 5.2
	 	Effect of Termination	  	7
		
	 ARTICLE VI  MISCELLANEOUS
	  	7
			
	 Section 6.1
	 	Survival of Representations and Warranties	  	7
	 Section 6.2
	 	Notices	  	7
	 Section 6.3
	 	Successors and Assigns; Third Party Beneficiaries	  	7
	 Section 6.4
	 	Amendment and Waiver	  	8
	 Section 6.5
	 	Counterparts	  	8

  

 i 

					
	 Section 6.6
	  	Headings	  	8
	 Section 6.7
	  	Governing Law; Consent to Jurisdiction; Waiver of Jury Trial	  	8
	 Section 6.8
	  	Severability	  	9
	 Section 6.9
	  	Specific Performance	  	9
	 Section 6.10
	  	Rules of Construction	  	9
	 Section 6.11
	  	Entire Agreement	  	9
	 Section 6.12
	  	Further Assurances	  	9

  

			
	SCHEDULES	  	 
		
	 Schedule I
	  	Exchanging Noteholders

  

 ii 

 NOTE EXCHANGE AGREEMENT 
 THIS NOTE EXCHANGE AGREEMENT, dated December 5, 2007 (this “Agreement”), among Critical Path, Inc., a California corporation (the
“Company”) and the persons set forth on Schedule I attached hereto (each, an “Exchanging Noteholder” and together, the “Exchanging Noteholders”). 
 WHEREAS, each Exchanging Noteholder owns the 13.9% Senior Notes having the aggregate principal amount set forth opposite the name of such Exchanging
Noteholder on Schedule I hereto (the “Notes”) of the Company; 
 WHEREAS, the Company has entered into that certain
Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”) with CP Holdco, LLC, a Delaware limited liability company (“Parent”) and CP Merger Co., a California corporation and a wholly owned
subsidiary of Parent; 
 WHEREAS, in connection with the Merger Agreement, the Company has proposed to effect, subject to the Company
Shareholder Approval (as defined in the Merger Agreement), that certain Amended and Restated Articles of Incorporation (the “Restated Articles”); 
 WHEREAS, subject to the satisfaction or waiver of the conditions set forth herein, the Exchanging Noteholders wish to exchange, immediately after the conversion (the “Conversion Completion”) of all
then outstanding shares of Series D Cumulative Redeemable Convertible Preferred Stock, par value $0.001 per share, of the Company (the “Series D Preferred Stock”) and Series E Redeemable Convertible Preferred Stock, par value $0.001
per share, of the Company (the “Series E Preferred Stock”) into shares of common stock of the surviving corporation of the merger contemplated by the Merger Agreement, par value $0.001 per share (the “Common
Stock”), and the Company wishes to accept, all of the then outstanding Notes for shares of Common Stock, at a per share price equal to $0.102 (subject to adjustment for stock splits, combinations, recapitalizations and similar antidilution
events), and 
 WHEREAS, the Company proposes, in connection and simultaneously with the exchange of the Notes pursuant to the terms hereof,
to cancel all outstanding warrants to purchase shares of Series F Redeemable Convertible Preferred Stock of the Company, par value $0.001 per share (the “Series F Warrants”). 
 NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the parties hereto agree as follows: 

 ARTICLE I 
 EXCHANGE OF NOTES FOR COMMON STOCK 
 Section 1.1 Exchange of the Notes; Cancellation of the
Series F Warrants. Subject to the terms and conditions herein set forth, each Exchanging Noteholder hereby agrees, severally and not jointly, to exchange its Notes on the Closing Date (as defined below) for, and the Company hereby agrees to
accept such Notes for cancellation and issue to such Exchanging Noteholder on the Closing Date, the aggregate number of shares of Common Stock equal to a fraction, the numerator of which is the outstanding principal amount of such Notes, together
with all interest accrued thereon up to and including the Closing Date, and the denominator of which is $0.102 (subject to adjustment for stock splits, combinations, recapitalizations and similar anti-dilution events with respect to the Common
Stock). The shares of Common Stock to be issued by the Company in exchange for all of the Notes are hereinafter referred to as the “Exchanged Shares”. Upon the surrender of the Notes in exchange for the Exchanged Shares, all then
outstanding principal amount of such Notes, together with all interest accrued thereon up to and including the Closing Date shall be deemed satisfied and such Notes shall be forthwith cancelled. Subject to the terms and conditions herein set forth,
each Exchanging Noteholder hereby further agrees, severally and not jointly, that the Series F Warrants held by such Exchanging Noteholders shall be cancelled at the Effective Time (as defined in the Merger Agreement) pursuant to Section 1.09
of the Merger Agreement. 
 Section 1.2 Closing. Subject to the satisfaction or waiver of the conditions set forth in Article IV
herein, the closing of the exchange of the Notes and issuance of the Exchanged Shares (the “Closing”) shall take place at the offices of Paul, Weiss, Rifkind, Wharton & Garrison LLP at 1285 Avenue of the Americas, New York,
New York 10019 immediately after the Conversion Completion (the date upon which the Closing occurs, the “Closing Date”). At the Closing, the Company shall deliver to each Exchanging Noteholder a certificate or certificates in
definitive form and registered in the name of each such Exchanging Noteholder, representing his or its Exchanged Shares against delivery by such Exchanging Noteholder to the Company, for cancellation, of the Notes held by such Exchanging Noteholder.

 Section 1.3 No Transfer. Prior to the earlier of the Closing and termination of this Agreement pursuant to Section 5.1,
except with the prior written consent of the Company, no Exchanging Noteholder shall sell, give, assign, hypothecate, pledge, encumber, grant a security interest in or otherwise dispose of (whether by operation of law or otherwise) any of its Notes.

 ARTICLE II 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 The Company represents and warrants to each of the Exchanging Noteholders as
follows: 
  

 2 

 Section 2.1 Corporate Existence and Power. The Company (a) is a corporation duly
organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation and (b) has the corporate power and authority to execute, deliver and perform its obligations under this Agreement. 
 Section 2.2 Authorization, No Conflicts. The execution, delivery and performance by the Company of this Agreement and the transactions
contemplated hereby (a) have been duly authorized by all necessary corporate action of the Company; (b) do not violate or conflict with the terms of its articles of incorporation or by-laws; (c) do not violate, conflict with or result
in any breach, default or contravention of (or with due notice or lapse of time or both would result in any breach, default or contravention of), or the creation of any lien under, any contractual obligation of the Company or any requirement of law
applicable to the Company; and (d) do not violate any judgment, injunction, writ, award, decree or order of any nature of any governmental authority against, or binding upon, the Company. 
 Section 2.3 Binding Effect. This Agreement has been duly executed and delivered by the Company, and constitutes the legal, valid and binding
obligations of the Company, enforceable against the Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws
affecting the enforcement of creditors’ rights generally and by general principles of equity relating to enforceability (regardless of whether considered in a proceeding at law or in equity). 
 Section 2.4 Approvals and Consents. No approval, consent, compliance, exemption, authorization or other action by, or notice to, or
registration, declaration or filing with, any governmental authority or any other person or entity, and no lapse of a waiting period under a requirement of law, is necessary or required in connection with the execution, delivery or performance
(including, without limitation, the issuance and delivery of the Exchanged Shares) by, or enforcement against, the Company of this Agreement or the consummation of the transactions contemplated hereby. 
 Section 2.5 Issuance of Exchanged Shares. The Exchanged Shares to be issued to each Exchanging Noteholder under this Agreement will be duly
and validly issued, fully paid and nonassessable, free and clear of any transfer restrictions or liens (other than as provided by applicable law), and not subject to any preemptive rights, rights of first refusal or other similar rights. All of the
Exchanged Shares will be, on the Closing Date, duly authorized, validly issued, fully paid and non-assessable, and will be issued in compliance with the registration and qualification requirements of all applicable federal, state and foreign
securities laws. The Notes set forth on Schedule I are all of the issued and outstanding Notes and there are no options, warrants, conversion privileges, purchase or other rights outstanding to purchase or acquire any Notes from the Company.

  

 3 

 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES OF THE EXCHANGING NOTEHOLDERS 
 Each Exchanging Noteholder represents
and warrants, severally and not jointly, to the Company as follows: 
 Section 3.1 Existence and Power. Such Exchanging Noteholder
(a) is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization and (b) has the capacity or power and authority to execute, deliver and perform its obligations under this
Agreement. 
 Section 3.2 Authorization, No Conflicts. The execution, delivery and performance by such Exchanging Noteholder of
this Agreement and the transactions contemplated hereby (a) have been duly authorized by all necessary action of such Exchanging Noteholder; (b) do not violate or conflict with the terms of its organizational or governing documents;
(c) do not violate, conflict with or result in any breach, default or contravention of (or with due notice or lapse of time or both would result in any breach, default or contravention of), or the creation of any lien under, any contractual
obligation of such Exchanging Noteholder or any requirement of law applicable to such Exchanging Noteholder; and (d) do not violate any judgment, injunction, writ, award, decree or order of any nature of any governmental authority against, or
binding upon, such Exchanging Noteholder. 
 Section 3.3 Binding Effect. This Agreement has been duly executed and delivered by
such Exchanging Noteholder, and constitutes the legal, valid and binding obligations of such Exchanging Noteholder, enforceable against such Exchanging Noteholder in accordance with its terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement of creditors’ rights generally and by general principles of equity relating to enforceability (regardless of whether
considered in a proceeding at law or in equity). 
 Section 3.4 Approvals and Consents. No approval, consent, compliance,
exemption, authorization or other action by, or notice to, or registration, declaration or filing with, any governmental authority or any other person or entity, and no lapse of a waiting period under a requirement of law, is necessary or required
in connection with the execution, delivery or performance by, or enforcement against, such Exchanging Noteholder of this Agreement or the consummation of the transactions contemplated hereby. 
 Section 3.5 Status of Exchanging Noteholder. Such Exchanging Noteholder is an “accredited investor” as defined in Rule 501(a) under
the Securities Act of 1933, as amended (the “Securities Act”). 
  

 4 

 Section 3.6 Purchase for Own Account. The Exchanged Shares to be acquired by such Exchanging
Noteholder pursuant to this Agreement are being or will be acquired for its own account and with no intention of distributing or reselling such Exchanged Shares or any part thereof. If such Exchanging Noteholder should in the future decide to
dispose of any such Exchanged Shares, such Exchanging Noteholder understands and agrees that it may do so only in compliance with the Securities Act and applicable state securities laws, as then in effect. Such Exchanging Noteholder agrees to the
imprinting, so long as required by law, of a legend on certificates representing all of its Exchanged Shares to the following effect: 
 THE
SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OF AMERICA. THE SHARES MAY NOT BE TRANSFERRED
EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS OR PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS. 
 Section 3.7 Title to Notes. Such Exchanging Noteholder is the true and lawful owner of its Notes having the aggregate principal amount set
forth opposite its name on Schedule I and such Notes are free and clear of all liens, restrictions, charges, adverse claims and other encumbrances (other than liens that would be released prior to the Closing and applicable restrictions under
state and federal securities laws). 
 Section 3.8 Pre-existing Relationship. Such Exchanging Noteholder has either a preexisting
personal or business relationship with the Company or one or more of its officers, directors or controlling Persons or, by reason of such Exchanging Noteholder’s business or financial experience or the business or financial experience of its
professional advisors who are unaffiliated with and who are not compensated by the Company or any Affiliate or any selling agent of the Company, directly or indirectly, have, and could reasonably be assumed to have, the capacity to protect its own
interests in connection with the issuance of the Exchanged Shares to such Exchanging Noteholder. 
 Section 3.9 No Advertising.
Such Exchanging Noteholder is not aware of the publication of any advertisement or of any general solicitation or advertising in connection with the offer and sale of the Exchanged Shares. 
 ARTICLE IV 
 CONDITIONS TO THE OBLIGATION 
 OF THE PARTIES TO CLOSE 
 Section 4.1 Conditions to the Obligations of the Exchanging Noteholders to Close. The obligations of each Exchanging Noteholder to acquire the Exchanged Shares, to deliver the Notes to the Company for cancellation therefor at
the 

  

 5 

 
Closing and to perform any obligations hereunder shall be subject to the satisfaction as determined by, or waived by, such Exchanging Noteholder in its sole
discretion, of the following conditions on or before the Closing Date: 
 (a) Representations and Warranties; Compliance. The
representations and warranties of the Company contained in Article II hereof shall be true and correct in all respects. The Company shall have performed and complied in all respects with all of its agreements set forth herein that are required to be
performed by the Company on or before the Closing Date. 
 (b) Merger Agreement. The Effective Time shall have occurred. 

(c) Restated Articles. The Restated Articles shall have been duly filed with the Secretary of State of the State of California and shall be in
full force and effect. 
 (d) Conversion Completion. The Conversion Completion shall have occurred. 
 Section 4.2 Conditions to the Obligations of the Company to Close. The obligations of the Company to issue the Exchanged Shares at the
Closing and to perform any obligations hereunder shall be subject to the satisfaction as determined by, or waived by, the Company in its sole discretion, of the following conditions on or before the Closing Date: 
 (a) Representations and Warranties; Compliance. The representations and warranties of each Exchanging Noteholder contained in Article III hereof
shall be true and correct in all respects. Each Exchanging Noteholder shall have performed and complied in all respects with all of its agreements set forth herein that are required to be performed by such Exchanging Noteholder on or before the
Closing Date. 
 (b) Merger Agreement. The Effective Time shall have occurred. 
 (c) Restated Articles. The Restated Articles shall have been duly filed with the Secretary of State of the State of California and shall be in
full force and effect. 
 (d) Conversion Completion. The Conversion Completion shall have occurred. 
 ARTICLE V 
 TERMINATION

 Section 5.1 Termination. This Agreement shall terminate automatically, without any action on the part of any party hereto,
upon the termination of the Merger Agreement in accordance with its terms. In no event shall any party be liable for any consequential, speculative or punitive damages or any damages arising from lost profits. 
  

 6 

 Section 5.2 Effect of Termination. In the event of termination of this Agreement as provided
in Section 5.1, this Agreement shall forthwith become void and have no effect; provided, that such termination shall not relieve any party for any material breach of this Agreement by such party prior to such termination. 
 ARTICLE VI 
 MISCELLANEOUS

 Section 6.1 Survival of Representations and Warranties. All of the representations and warranties made herein shall
survive the execution and delivery of this Agreement. 
 Section 6.2 Notices. All notices, demands and other communications
provided for or permitted hereunder shall be made in writing and shall be by registered or certified first-class mail, return receipt requested, telecopier, courier service or personal delivery: 
 If to the Company: 
 Critical Path, Inc.

 2 Harrison Street, 2nd Floor 
 San Francisco, California 94105 
 Telecopier: (415) 541-2300 
 Attention: Chief Executive Officer 
 with a
copy to: 
 Paul, Hastings, Janofsky & Walker, LLP 
 55 Second Street, 24th Floor 
 San Francisco, California 94105 
 Telecopier: (415) 856-7310 
 Attention:
Gregg F. Vignos, Esq. 
 If to any Exchanging Noteholders, at the addresses of such Exchanging Noteholder set forth on Schedule I
attached hereto. 
 All such notices, demands and other communications shall be deemed to have been duly given when delivered by hand, if
personally delivered; when delivered by courier, if delivered by commercial courier service; five (5) Business Days after being deposited in the mail, postage prepaid, if mailed; and when receipt is mechanically acknowledged, if telecopied.

 Section 6.3 Successors and Assigns; Third Party Beneficiaries. This Agreement shall inure to the benefit of and be binding
upon the successors of the parties 

  

 7 

 
hereto. No Person other than the parties hereto and their successors are intended to be a beneficiary of this Agreement. 
 Section 6.4 Amendment and Waiver. Any amendment, supplement or modification of or to
any provision of this Agreement, any waiver of any provision of this Agreement, and any consent to any departure by the Company or the Exchanging Noteholders from the terms of any provision of this Agreement, shall be effective (i) only if it
is made or given in writing and signed by the Company and the Exchanging Noteholders holding two-thirds ( 2/3) of the aggregate principal amount of the Notes set forth on Schedule I hereto and (ii) only in the specific instance and for the specific purpose for which it is made or given. Any such amendment, supplement,
modification, waiver or consent shall be binding upon all of the Exchanging Noteholders. 
 Section 6.5 Counterparts. This
Agreement may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.

 Section 6.6 Headings. The headings in this Agreement are for convenience of reference only and shall not limit or otherwise
affect the meaning hereof. 
 Section 6.7 Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be
construed, and the rights and obligations of the parties hereunder determined, in accordance with and governed by the law of the state of Delaware. The parties hereto irrevocably submit to the exclusive jurisdiction of any state or federal court
sitting in the State of Delaware over any suit, action or proceeding arising out of or relating to this Agreement. To the fullest extent they may effectively do so under applicable law, the parties hereto irrevocably waive and agree not to assert,
by way of motion, as a defense or otherwise, any claim that they are not subject to the jurisdiction of any such court, any objection that they may now or hereafter have to the laying of the venue of any such suit, action or proceeding brought in
any such court and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY
JURY IN CONNECTION WITH ANY MATTER RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. EACH OF THE PARTIES HERETO HEREBY (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF THE OTHER PARTIES HAS REPRESENTED, EXPRESSLY OR
OTHERWISE, THAT SUCH OTHER PARTIES WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY, AS APPLICABLE,
AMONG OTHER THINGS, BY THE MUTUAL WAIVERS AND CERTIFICATIONS SET FORTH IN THIS SECTION. 
  

 8 

 Section 6.8 Severability. If any one or more of the provisions contained herein, or the
application thereof in any circumstance, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions hereof shall not
be in any way impaired, unless the provisions held invalid, illegal or unenforceable shall substantially impair the benefits of the remaining provisions hereof. 
 Section 6.9 Specific Performance. The parties to this Agreement agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance
with their specific terms or were otherwise breached. It is accordingly agreed that the parties will be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this
Agreement, this being in addition to any other remedy to which the parties are entitled at law or in equity. 
 Section 6.10 Rules of
Construction. Unless the context otherwise requires, references to sections or subsections refer to sections or subsections of this Agreement. 
 Section 6.11 Entire Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in
respect of the subject matter contained herein. There are no restrictions, promises, representations, warranties or undertakings, other than those set forth or referred to herein. This Agreement supersedes all prior agreements and understandings
between the parties with respect to such subject matter. 
 Section 6.12 Further Assurances. Each of the parties shall execute
such documents and perform such further acts (including, without limitation, obtaining any consents, exemptions, authorizations or other actions by, or giving any notices to, or making any filings with, any governmental authority or any other
person) as may be reasonably required or desirable to carry out or to perform the provisions of this Agreement. 
 [Remainder of page
intentionally left blank] 
  

 9 

 IN WITNESS WHEREOF, the undersigned have executed, or have caused to be executed, this Note Exchange
Agreement on the date first written above. 
  

			
	CRITICAL PATH, INC.
		
	By:	 	 /s/ Mark Palomba

	Name:	 	Mark Palomba
	Title:	 	Chief Executive Officer
	
	 EXCHANGING NOTEHOLDERS:
  
 GENERAL ATLANTIC PARTNERS 74, L.P.

		
	By:	 	General Atlantic LLC,
		 	Its general partner
		
	By:	 	 /s/ Matthew Nimetz

	Name:	 	Matthew Nimetz
	Title:	 	Managing Director
	
	GAPSTAR, LLC
		
	By:	 	General Atlantic LLC,
		 	Its sole member
		
	By:	 	 /s/ Matthew Nimetz

	Name:	 	Matthew Nimetz
	Title:	 	Managing Director

			
	GAP COINVESTMENT PARTNERS II, L.P.
		
	By:	 	 /s/ Matthew Nimetz

	Name:	 	Matthew Nimetz
	Title:	 	A General Partner
	
	GAPCO GMBH & CO. KG.
		
	By:	 	GAPCO Management GmbH,
		 	Its general partner
		
	By:	 	 /s/ Matthew Nimetz

	Name:	 	Matthew Nimetz
	Title:	 	Managing Director
	
	EXCHANGING NOTEHOLDER:
	
	CAMPINA ENTERPRISES LIMITED
		
	By:	 	 /s/ Ip Tak Chuen, Edmond

	Name:	 	Ip Tak Chuen, Edmond
	Title:	 	Director
	
	EXCHANGING NOTEHOLDER:
	
	RICHMOND CP LLC
		
	By:	 	 /s/ Peter B. Kellner

	Name:	 	Peter Kellner
	Title:	 	Managing Member

  

 SCHEDULE I 
 EXCHANGING NOTEHOLDERS 
  

				
	 Exchanging Noteholder
	  	Principal Amount of Notes
	 General Atlantic Partners 74, L.P.
  
 c/o General Atlantic Service Company, LLC
 3 Pickwick Plaza
 Greenwich, CT 06830
 Telecopier: (203) 302-3044
 Attention: David A. Rosenstein
	  	$	6,841,995.29
		
	 GapStar, LLC
  
 c/o General Atlantic Service Company, LLC
 3 Pickwick Plaza
 Greenwich, CT 06830
 Telecopier: (203) 302-3044
 Attention: David A. Rosenstein
	  	$	530,073.19
		
	 GAP Coinvestment Partners II, L.P.
  
 c/o General Atlantic Service Company, LLC
 3 Pickwick Plaza
 Greenwich, CT 06830
 Telecopier: (203) 302-3044
 Attention: David A. Rosenstein
	  	$	864,571.92
		
	 GAPCO GmbH & Co. KG
  

Koenigsallee 62
 40212 Duesseldorf
 Germany
 Telecopier: 49 211 602 888-57
 Attention: David A. Rosenstein
	  	$	13,359.60
		
	 Campina Enterprises Limited
  

c/o 7th Floor, Cheung Kong Center
 2 Queen’s Road Central
 Hong Kong
 Telecopier: (852) 2128-8001
 Attention: Company Secretary
	  	$	8,250,000.00

				
	 Richmond CP LLC
  
 c/o Richmond Management LLC
 645 Madison Avenue, 20th Floor
 New York, NY 10022
 Telecopier: (212) 838-6742
 Attention: Peter B. Kellner
	  	$	1,500,000.00

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]